Subgroups according to BASDAI/ASDAS category (baseline)
Por um escritor misterioso
Descrição
PDF) Eligibility criteria for biologic disease-modifying antirheumatic drugs in axial spondyloarthritis: going beyond BASDAI
Frontiers The BASDAI Cut-Off for Disease Activity Corresponding to the ASDAS Scores in a Taiwanese Cohort of Ankylosing Spondylitis
Full article: POSTER PRESENTATIONS
Baseline characteristics of ASDAS ID and ASAS PR responders and
Effects of ixekizumab treatment on structural changes in the sacroiliac joint: MRI assessments at 16 weeks in patients with non-radiographic axial spondyloarthritis - The Lancet Rheumatology
Poor prognostic factors in predicting abatacept response in a phase III randomized controlled trial in psoriatic arthritis
Frontiers The BASDAI Cut-Off for Disease Activity Corresponding to the ASDAS Scores in a Taiwanese Cohort of Ankylosing Spondylitis
Construct validity and responsiveness of the simplified version of Ankylosing Spondylitis Disease Activity Score (SASDAS) for the evaluation of disease activity in axial spondyloarthritis, Health and Quality of Life Outcomes
WO2021067465A1 - Treating spondyloarthritic and psoriatic conditions with upadacitinib - Google Patents
de
por adulto (o preço varia de acordo com o tamanho do grupo)
